In vitro and in vivo effects of deoxyribonucleic acid-based coatings funtionalized with vascular endothelial growth factor.
Publication year
2007Source
Tissue Engineering, 13, 4, (2007), pp. 711-20ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Periodontology and Biomaterials
Biochemistry (UMC)
Synthetic Organic Chemistry
Physical Organic Chemistry
Former Organization
Physical Organic and Supramolecular Chemistry
Journal title
Tissue Engineering
Volume
vol. 13
Issue
iss. 4
Page start
p. 711
Page end
p. 20
Subject
IGMD 9: Renal disorder; NCMLS 1: Immunity, infection and tissue repair; NCMLS 3: Tissue engineering and pathology; NCMLS 7: Chemical and physical biology; Physical Organic Chemistry; UMCN 4.3: Tissue engineering and reconstructive surgeryAbstract
Vascularization is important in wound healing and essential for tissue ingrowth into porous tissue-engineering matrices. Furthermore, peri-implant tissue vascularization is known to be important for the functionality of subcutaneously implanted biosensors (e.g., glucose sensors). As a first exploration of the use of deoxyribonucleic acid (DNA)-based coatings for the optimization of biosensor functionality, this study focused on the effect of DNA-based coatings functionalized with vascular endothelial growth factor (VEGF) on in vitro endothelial cell behavior and vascularization of the peri-implant tissue in vivo. To that end, DNA-based coatings consisting of poly-D-lysine and DNA were functionalized with different amounts of VEGF (25 and 250 ng) and compared to non-coated controls and non-functionalized DNA-based coatings. The results demonstrated the superiority of VEGF-functionalized DNA-based coatings in increasing endothelial cell proliferation and migration in vitro over non-coated controls and non-functionalized DNA-based coatings. In vivo, a significant increase in vascularization of the peri-implant area was observed for VEGF-functionalized DNA-based coatings. Because no dosage-dependent effects were observed, future experiments should focus on optimizing VEGF concentration for this purpose. Additionally, the administration of VEGF in combination with other (pro-angiogenic) factors should be considered.
This item appears in the following Collection(s)
- Academic publications [232155]
- Electronic publications [115359]
- Faculty of Medical Sciences [89071]
- Faculty of Science [34958]
- Open Access publications [82671]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.